TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules AC McShan, CA Devlin, GF Papadaki, Y Sun, AI Green, GI Morozov, ... Nature chemical biology 18 (8), 859-868, 2022 | 17 | 2022 |
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes Y Sun, GF Papadaki, CA Devlin, JN Danon, MC Young, TJ Winters, ... Science Advances 9 (8), eade7151, 2023 | 7 | 2023 |
Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypes Y Sun, MC Young, CH Woodward, JN Danon, HV Truong, S Gupta, ... Proceedings of the National Academy of Sciences 120 (25), e2304055120, 2023 | 5 | 2023 |
Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules GF Papadaki, O Ani, TJ Florio, MC Young, JN Danon, Y Sun, D Dersh, ... Frontiers in Immunology 14, 1116906, 2023 | 3 | 2023 |
Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion Y Sun, TJ Florio, S Gupta, MC Young, QF Marshall, SE Garfinkle, ... Science immunology 8 (90), eadj5792, 2023 | 2 | 2023 |
Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition AC McShan, D Flores-Solis, Y Sun, SE Garfinkle, JS Toor, MC Young, ... Nature Communications 14 (1), 8204, 2023 | 1 | 2023 |